BackAurora Spine Overview

Aurora Spine EBIT

Latest ebit for ASG.V: $-810K, below the sector sector average of $2.6T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$778.41K
↓ 397.09% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$814.65K
↑ 14.8% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Aurora Spine (ASG.V) FAQ

The latest EBIT for ASG.V is $-810K as of June 2026. That compares with $-960K in the prior-year period — up 14.8% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Aurora Spine's historical trend and sector peers before judging valuation or financial health.

Over the past year, ASG.V's EBIT moved from $-960K to $-810K — a 14.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aurora Spine's operating scale or balance-sheet position.

Against its sector companies, ASG.V currently prints $-810K for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Aurora Spine's growth, margins, and balance sheet.

A EBIT figure of $-810K for ASG.V is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting ASG.V's EBIT ($-810K), review year-over-year change from $-960K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.